This is a discussion on Sanofi: Acomplia demonstrates better glucose control within the Biotechnology News forum, part of the Industry News and Updates category; Sanofi-Aventis said that a trial of Acomplia showed a significant improvement in glucose control in comparison to insulin among ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Sanofi-Aventis said that a trial of Acomplia showed a significant improvement in glucose control in comparison to insulin among patients with type 2 diabetes. Glucose control was three times more Read more...
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| A Case Control Study to Assess Association of Variations in OCT Genes with Effectiveness of Metformin in Diabetic Patien | industry_news | Comparative Effectiveness Updates | 0 | 06-01-2008 01:55 PM |